5-Amino-1MQ is a small molecule inhibitor of the enzyme NNMT (Nicotinamide N-methyltransferase), studied for its effects on NAD+ metabolism, adipocyte function, and cellular energy regulation. Research has examined 5-Amino-1MQ in the context of metabolic syndrome, obesity biology, and cellular energy availability. Supplied as a 100mg lyophilised powder at ≥99% purity. Premium Series includes priority processing and enhanced packaging. Full independent CoA per batch. For research use only.
Also Available
Other Related Peptides
NAD+ pathway research compound. 100mg lyophilised powder. 99% purity. Premium Series — CoA and priority dispatch included.
$90.00 – $225.00Price range: $90.00 through $225.00
Premium-grade Retatrutide 20mg — the highest-demand research peptide in the range. Triple GLP-1/GIP/GCGR agonist. Independent CoA. Priority dispatch.
$250.00
Synthetic anxiolytic heptapeptide for neuroscience and anxiety pathway research. 5mg lyophilised powder. 99% purity. CoA included.
$75.00
Synthetic ACTH-derived peptide for neurological and cognitive research. 30mg lyophilised powder. 99% purity. CoA included.
$85.00
Modified fragment of human growth hormone for lipolysis and metabolic research. 5mg lyophilised powder. 99% purity. CoA included.
$70.00
Mitochondrial-derived peptide for metabolic and mitochondrial function research. 10mg lyophilised powder. 99% purity. CoA included.
$120.00
Researcher Feedback
What Researchers Say
★★★★★
“Ordering process was clean and professional. The CoA matched exactly what I needed for documentation. Purity figures held up against our in-house testing. Will be reordering.”
JR
J. Reynolds
Independent Research Buyer, VIC
★★★★★
“The batch documentation is the best I’ve encountered from an Australian supplier. Transparent, complete, and the dispatch was genuinely fast. Exactly what I needed.”
JR
S. Morrison
Research Procurement, QLD
★★★★★
“Ordering process was clean and professional. The CoA matched exactly what I needed for documentation. Purity figures held up against our in-house testing. Will be reordering.”
JR
A. Langford
Laboratory Researcher, NSW
